Berberis aetnensis and B. libanotica: A comparative study on the chemical composition, inhibitory effect on key enzymes linked to Alzheimer's disease and antioxidant activity

Journal of Pharmacy and Pharmacology

Volumn 65, Issue 12, 2013, Pages 1726-1735

  Bonesi, Marco ^a   Loizzo, Monica R ^a   Conforti, Filomena ^a   Passalacqua, Nicodemo G ^a   Saab, Antoine ^b   Menichini, Federica ^c   Tundis, Rosa ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

^b LEBANESE UNIVERSITY   (Lebanon)

^c ITALIAN MEDICINES AGENCY   (Italy)

Author keywords

alkaloids; anticholinesterase activity; antioxidant activity; Berberis aetnensis; Berberis libanotica

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 5 EICOSENE; 9,12 OCTADECADIEN 1 OL; ACETYLCHOLINESTERASE; ALKALOID; ANTIOXIDANT; ASCORBIC ACID; BERBERINE; BERBERIS AETNENSIS EXTRACT; BERBERIS LIBANOTICA EXTRACT; BETA CAROTENE; CAMPESTEROL; CARVACROL; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; CYCLODODECENE; CYCLOEUCALENOL; GALLIC ACID PROPYL ESTER; HEXANE; METHANOL; MYRISTIC ACID; PALMATINE; PALMITIC ACID; PLANT EXTRACT; STIGMAST 4 EN 3 ONE; STIGMAST 4,22 DIEN 3 ONE; STIGMAST 4,22 DIENE; STIGMASTEROL; THYMOL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; BERBERIS AETNENSIS; BERBERIS LIBANOTICA; CHEMICAL COMPOSITION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG POTENCY; ENZYME INHIBITION; GAS CHROMATOGRAPHY; IC 50; MASS SPECTROMETRY; NONHUMAN; PLANT ROOT;

ALKALOIDS; ANTICHOLINESTERASE ACTIVITY; ANTIOXIDANT ACTIVITY; BERBERIS AETNENSIS; BERBERIS LIBANOTICA;

ALKALOIDS; ALZHEIMER DISEASE; ANTIOXIDANTS; BERBERINE; BERBERIS; CHOLINESTERASE INHIBITORS; HUMANS; OXIDATIVE STRESS; PLANT EXTRACTS;

EID: 84887942949     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12172     Document Type: Article

References (48)

1. Ivanovska N, Philipov S,. Study of the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids. Int J Immunopharmacol 1996; 18: 553-561.
2. Musumeci R, et al. Berberis aetnensis C. Presl. extracts: antimicrobial properties and interaction with ciprofloxacin. Int J Antimicrob Agents 2003; 22: 48-53.
3. Birdsall TC, Kelly GS,. Berberine: therapeutic potential of an alkaloid found in several medicinal plants. Altern Med Rev 1997; 2: 94-103.
4. Blumenthal M, et al. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicine. Austin, TX: American Botanical Council, 1998: 309-310.
5. Tomosaka H, et al. Antioxidant and cytoprotective compounds from Berberis vulgaris (barberry). Phytother Res 2008; 22: 979-981.
6. Asif A, et al. Wound healing activity of root extracts of Berberis lyceum Royle in rats. Phytother Res 2007; 21: 589-591.
7. Iauk L, et al. Activity of Berberis aetnensis root extracts on Candida strains. Fitoterapia 2007; 78: 159-161.
8. Campisi A, et al. Effect of berberine and Berberis aetnensis C. Presl. alkaloid extract on glutamate-evoked tissue transglutaminase up-regulation in astroglial cell cultures. Phytother Res 2011; 25: 816-820.
9. Esseily F, et al. The ethanol fraction from the stem of Berberis libanotica inhibits the viability of adult T cell leukemia. Minerva Biotecnol 2012; 24: 129-133.
10. Yoo KY, et al. Berberry extract reduces neuronal damage and N-methyl-D-aspartate receptor 1 immunoreactivity in the gerbil hippocampus after transient forebrain ischemia. Biol Pharm Bull 2006; 29: 623-628.
11. Habtemariam S,. The therapeutic potential of Berberis darwinii stem-bark: quantification of berberine and in vitro evidence for Alzheimer's disease therapy. Nat Prod Commun 2011; 6: 1089-1090.
12. Küpeli E, et al. A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species. Life Sci 2002; 72: 645-657.
13. Kulkarni SK, Dhir A,. Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride. Eur J Pharmacol 2007; 569: 77-83.
14. Shigeta K, et al. Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by a Coptidis rhizoma extract and protoberberine alkaloids. Biosci Biotechnol Biochem 2002; 66: 2491-2494.
15. Cui HS, et al. Berberine exerts neuroprotective actions against in vitro ischemia-induced neuronal cell damage in organotypic hippocampal slice cultures: involvement of B-cell lymphoma 2 phosphorylation suppression. Biol Pharm Bull 2009; 32: 79-85.
16. Kim DK, et al. Acetylcholinesterase inhibitors from the aerial parts of Corydalis speciosa. Arch Pharm Res 2004; 27: 1127-1131.
17. Greig NH, et al. Butyrylcholinesterase: an important new target in Alzheimer's disease therapy. Int Psychogeriatr 2002; 14: 77-91.
18. Olanow CW,. A radical hypothesis for neurodegeneration. Trends Neurosci 1993; 16: 439-444.
19. Palmer AM, et al. Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease. Brain Res 1994; 645: 338-342.
20. Butterfield DA, et al. β-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem Biophys Res Commun 1994; 200: 710-715.
21. Blaskò G, et al. Carbon-13 NMR assignments of berberine and sanguinarine. Heterocycles 1988; 27: 911-916.
22. Wafo P, et al. A 7,8-dihydro-8-hydroxypalmatine from Enantia clorantha. Phytochemistry 1999; 50: 279-281.
23. Grycovà L, et al. Quaternary protoberberine alkaloids. Phytochemistry 2007; 68: 150-175.
24. Menichini F, et al. Acetylcholinesterase and butyrylcholinesterase inhibition of ethanolic extract and monoterpenes from Pimpinella anisoides V Brig. (Apiaceae). Fitoterapia 2009; 80: 297-300.
25. Marrelli M, et al. Comparative chemical composition and antioxidant activity of Calamintha nepeta (L.) Savi subsp. glandulosa (Req.) Nyman and Calamintha grandiflora (L.) Moench (Labiatae). Nat Prod Res 2012; 26: 91-97.
26. Conforti F, et al. Correlation between environmental factors, chemical composition, and antioxidative properties of caper species growing wild in Calabria (South Italy). Chem Biodivers 2011; 8: 518-531.
27. Zovko Končic̈ M, et al. Evaluation of antioxidant activities and phenolic content of Berberis vulgaris L. and Berberis croatica Horvat. Food Chem Toxicol 2010; 48: 2176-2180.
28. Agrawal S, et al. A comparative study on the antioxidant activity of methanol extracts of Acacia nilotica and Berberis chitria. Adv in Nat Appl Sci 2010; 4: 78-84.
29. Nostro A, et al. Extraction methods and bioautography for evaluation of medicinal plant antimicrobial activity. Lett Appl Microbiol 2001; 30: 379-384.
30. Andola HC, et al. Habitat-dependent variations in berberine content of Berberis asiatica Roxb. ex. DC. in Kumaon, Western Himalaya. Chem Biodivers 2010; 7: 415-420.
31. Khamidov II, et al. Berberis alkaloids. XLI. Alkaloids from leaves of cultivated Berberis oblonga. Chem Nat Comp 2003; 39: 407.
32. Singh IP, Mahajan S,. Berberine and its derivatives: a patent review (2009-2012). Expert Opin Ther Pat 2013; 23: 215-231.
33. Loizzo MR, et al. Natural products and their derivatives as cholinesterase inhibitors in the treatment of neurodegenerative disorders: an update. Curr Med Chem 2008; 15: 1209-1228.
34. Kolář D, et al. Acetylcholinesterase and Butyrylcholinesterase inhibitory activities of Berberis vulgaris. Phytopharmacology 2010; 1: 7-11.
35. Huang ZJ, et al. Advances in structural modifications and biological activities of berberine: an active compound in traditional Chinese medicine. Mini Rev Med Chem 2011; 11: 1122-1129.
36. Fukuda K, et al. Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J Ethnopharmacol 1999; 66: 227-233.
37. Wartenberg M, et al. Inhibition of tumor-induced angiogenesis and matrix-metalloproteinase expression in confrontation cultures of embryoid bodies and tumor spheroids by plant ingredients used in traditional Chinese medicine. Lab Invest 2003; 83: 87-98.
38. Singh J, Kakkar P,. Antihyperglycemic and antioxidant effect of Berberis aristata root extract and its role in regulating carbohydrate metabolism in diabetic rats. J Ethnopharmacol 2009; 123: 22-26.
39. Ji HF, Shen L,. Berberine: a potential multipotent natural product to combat Alzheimer's disease. Molecules 2011; 16: 6732-6740.
40. Hwang SY, et al. An acetylcholinesterase inhibitor isolated from Corydalis tuber and its mode of action. Korean J Pharmacogn 1996; 27: 91-95.
41. Aazza S, et al. Antioxidant and antiacetylcholinesterase activities of some commercial essential oils and their major compounds. Molecules 2011; 16: 7672-7690.
42. Orhan I, et al. Activity of essential oils and individual components against acetyl- and butyrylcholinesterase. Z Naturforsch 2008; 63c: 547-553.
43. Marksberry WR, Lovell MA,. Damage to lipids, proteins, DNA and RNA in mild cognitive impairment. Arch Neurol 2007; 64: 954-956.
44. Tuppo EE, Forman LJ,. Free radical oxidative damage and Alzheimer's disease. J Am Osteopath Assoc 2001; 101: S11-S15.
45. Gacche RN, Dhole NA,. Antioxidant and possible anti-inflammatory potential of selected medicinal plants prescribed in the Indian traditional system of medicine. Pharm Biol 2006; 44: 389-395.
46. Hanachi P, et al. Cytotoxic effect of Berberis vulgaris fruit extract on the proliferation of human liver cancer line (HepG2) and its antioxidant properties. Int J Cancer Res 2006; 2: 1-9.
47. Heinrich M, et al. Understanding local Mediterranean diets: a multidisciplinary pharmacological and ethnobotanical approach. Pharmacol Res 2005; 52: 353-366.
48. Halliwell B,. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 2001; 18: 685-716.